Meanwhile, TIGIT recognizes poliovirus receptor (PVR or CD155), Nectin-2 (CD112), or Nectin-3 overexpressed in hematologic cancers (203, 204). Here, PVR is linked to hematopoietic and lymphoid cell neoplasm.